Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Kleinerman

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndromeE S Kleinerman, L M Ceccorulli, L A Zwelling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in miceN V Koshkina, E S Kleinerman, C Waidrep, et al.
British Journal of Cancer|June 1, 1996
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposideT Asano, L A Zwelling, T An, et al.
Science (New York, N.Y.)|June 1, 1984
Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cellsW C Koff, I J Fidler, S D Showalter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transductionR A Gottlieb, W J Lennarz, R D Knowles, et al.
Lancet (London, England)|November 22, 1980
Defective monocyte killing in patients with malignancies and restoration of function during chemotherapyE S Kleinerman, L A Zwelling, D Howser, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid)E S Kleinerman, A K Raymond, C D Bucana, et al.
Oncogenesis|April 5, 2013
Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesA N Rettew, E D Young, D C Lev, et al.
Cancer Gene Therapy|October 11, 2001
Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexesC L Densmore, E S Kleinerman, A Gautam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patientsJ L Murray, E S Kleinerman, J E Cunningham, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndromeE S Kleinerman, L M Ceccorulli, L A Zwelling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in miceN V Koshkina, E S Kleinerman, C Waidrep, et al.
British Journal of Cancer|June 1, 1996
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposideT Asano, L A Zwelling, T An, et al.
Science (New York, N.Y.)|June 1, 1984
Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cellsW C Koff, I J Fidler, S D Showalter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transductionR A Gottlieb, W J Lennarz, R D Knowles, et al.
Lancet (London, England)|November 22, 1980
Defective monocyte killing in patients with malignancies and restoration of function during chemotherapyE S Kleinerman, L A Zwelling, D Howser, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid)E S Kleinerman, A K Raymond, C D Bucana, et al.
Oncogenesis|April 5, 2013
Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesA N Rettew, E D Young, D C Lev, et al.
Cancer Gene Therapy|October 11, 2001
Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexesC L Densmore, E S Kleinerman, A Gautam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patientsJ L Murray, E S Kleinerman, J E Cunningham, et al.
Pageof 9